Nanozymatic magnetic nanomotors for enhancing photothermal therapy and targeting intracellular SERS sensing.

Self-propelled micro/nanomotors (MNMs) have emerged as promising tools for biomedical applications owing to their active and controllable movement, which is achieved by converting energy derived from chemical reactions or external physical fields into mechanical forces. However, it remains a challenge to develop all-in-one MNMs that integrate multiple bio-friendly engines and biomedical functions. In this study, we present a nanozymatic magnetic nanomotor capable of self-propulsion, driven by its intrinsic engines, and possessing inherent biomedical functions. The nanomotors with a core-island structure are fabricated by a general scalable chemistry synthesis approach. The core of the nanomotors is magnetic Fe3O4 nanoparticles, while the surrounding islands consist of Au nanostars. Such components naturally equip the nanomotors with the dual engine of the magnetic core and gold nanozyme. In addition, the localized surface plasmon resonance (LSPR) effect of the Au nanostar imparts the nanomotors with favourable photothermal conversion and surface-enhanced Raman scattering (SERS) properties. The nanomotors exhibit glucose concentration-dependent motion behavior of enhanced diffusion, leading to improved endocytosis for enhanced photothermal treatment. When exposed to a magnetic field, the nanomotors demonstrate both directional locomotion towards target cells and up-and-down oscillatory movement, enabling the efficient gathering of intracellular analytes for SERS sensing. To conclude, the as-prepared nanomotors represent an active and controllable nanoplatform with a simple structure and are naturally equipped with dual engines and dual biomedical functions, providing new perspectives to the development of all-in-one biomedical MNMs.

A Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry.

A metabonomics approach based on liquid chromatography/quadrupole time-of-flight mass spectrometry (LC-Q-TOF/MS) was utilized to obtain potential biomarkers of coronary heart disease (CHD) patients and investigate the ZHENG types differentiation in CHD patients. The plasma samples of 20 CHD patients with phlegm syndrome, 20 CHD patients with blood-stasis syndrome, and 16 healthy volunteers were collected in the study. 26 potential biomarkers were identified in the plasma of CHD patients and 19 differential metabolites contributed to the discrimination of phlegm syndrome and blood-stasis syndrome in CHD patients (VIP > 1.5; P < 0.05) which mainly involved purine metabolism, pyrimidine metabolism, amino acid metabolism, steroid biosynthesis, and arachidonic acid metabolism. This study demonstrated that metabonomics approach based on LC-MS was useful for studying pathologic changes of CHD patients and interpreting the differentiation of ZHENG types (phlegm and blood-stasis syndrome) in traditional Chinese medicine (TCM).